Catalent Inc (NYSE:CTLT)
| 77.76 BATS BZX Real-Time Price As of 12:49pm ET |  -0.76 / -0.97%Today’s Change | 31.04 Today|||52-Week Range 80.48 | +38.12% Year-to-Date |
Latest CTLT News | Press Releases
No recent news for Catalent Inc.
Today’s Trading
| Previous close | 78.52 |
| Today’s open | 80.12 |
| Day’s range | 77.35 - 80.48 |
| Volume | 511,673 |
| Average volume (3 months) | 1,231,366 |
| Market cap | $12.2B |
Data as of 12:49pm ET, 05/26/2020
Growth & Valuation
| Earnings growth (last year) | +42.98% |
| Earnings growth (this year) | +1.83% |
| Earnings growth (next 5 years) | +10.47% |
| Revenue growth (last year) | +2.22% |
| P/E ratio | 111.0 |
| Price/Sales | 3.14 |
| Price/Book | 6.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SRPTSarepta Therapeutics... | +5.56 | +3.69% |
| GLPGGalapagos NV | +6.17 | +3.08% |
| HZNPHorizon Therapeutics... | +0.40 | +0.81% |
| RDYDr.Reddy's Laborator... | -0.34 | -0.66% |
Data as of 12:48pm ET, 05/26/2020
Financials
| Next reporting date | August 31, 2020 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $2.5B |
| Annual profit (last year) | $132.0M |
| Net profit margin | 5.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Somerset, New Jersey |
Forecasts
